ACADIA Pharmaceuticals Inc. (ACAD) Climbed 7.47% or 1.07 To Price $15.39 On Wednesday


ACADIA Pharmaceuticals Inc. (ACAD) climbed 7.47% or 1.07 to $15.39. It is close to 1.55 million shares traded, which is 61.82% compare to the average total volume 2.50 million. The market cap of ACAD is $1.92 billion. The year to date change is -45.47%. The 52 week price range is from $12.77 to $32.99. Price of ACAD have changed -15.96% during last week. It have changed -26.41% over last month, -32.13% over last 3 months, -12.15% over last 6 months and -52.99% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for ACAD is 19.60. It is 27.36% above current price. The 200-day Moving Averages for ACAD is 18.29. It is 18.84% above current price. The 52-week High is 32.99. It is 114.36% from the current price. The 52-week Low is 12.77. It is -17.02% from current price.

There are some statistics of ACAD. It is has market cap $1.92 billion. The share outstanding is 125.07 million. The average volume is 2.50 million. The percent of top 15 Institution holding is 151.30%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of ACAD is -82.75%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of ACAD is -73.09%.


Tags:

Share this post